Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Alan Howard

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Advanced Drug Delivery Reviews|April 10, 2009
Delivery of RNA interference therapeutics using polycation-based nanoparticlesKenneth Alan Howard
Nanomedicine (London, England)|August 12, 2009
Delivering the goods: realizing the clinical potential of RNAiKenneth Alan Howard
Journal of Drug Targeting|June 21, 2002
The development of polyplex-based DNA vaccinesKenneth Alan Howard, H Oya Alpar
Advanced Drug Delivery Reviews|July 18, 2012
Polycation-based nanoparticle delivery of RNAi therapeutics: adverse effects and solutionsBorja Ballarín-González, Kenneth Alan Howard
Methods in Molecular Biology (Clifton, N.J.)|June 5, 2009
RNAi using a chitosan/siRNA nanoparticle system: in vitro and in vivo applicationsMorten Østergaard Andersen, Kenneth Alan Howard, Jørgen Kjems
Cancer Letters|October 22, 2013
Polycation-based nanoparticles for RNAi-mediated cancer treatmentBorja Ballarín-González, Morten Frendø Ebbesen, Kenneth Alan Howard
Drug Delivery and Translational Research|March 20, 2015
Clinical translation of RNAi-based treatments for respiratory diseasesBorja Ballarín-González, Troels Bo Thomsen, Kenneth Alan Howard
Drug Delivery and Translational Research|March 20, 2015
The application of RNAi-based treatments for inflammatory bowel diseaseMorten Tobias Jarlstad Olesen, Borja Ballarín-González, Kenneth Alan Howard
Journal of Drug Targeting|June 18, 2009
Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epitheliumAlpesh Mistry, Sys Zoffmann Glud, Jørgen Kjems, et al.
ACS Nano|May 25, 2012
Chitosan/siRNA nanoparticles encapsulated in PLGA nanofibers for siRNA deliveryMenglin Chen, Shan Gao, Mingdong Dong, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Advanced Drug Delivery Reviews|April 10, 2009
Delivery of RNA interference therapeutics using polycation-based nanoparticlesKenneth Alan Howard
Nanomedicine (London, England)|August 12, 2009
Delivering the goods: realizing the clinical potential of RNAiKenneth Alan Howard
Journal of Drug Targeting|June 21, 2002
The development of polyplex-based DNA vaccinesKenneth Alan Howard, H Oya Alpar
Advanced Drug Delivery Reviews|July 18, 2012
Polycation-based nanoparticle delivery of RNAi therapeutics: adverse effects and solutionsBorja Ballarín-González, Kenneth Alan Howard
Methods in Molecular Biology (Clifton, N.J.)|June 5, 2009
RNAi using a chitosan/siRNA nanoparticle system: in vitro and in vivo applicationsMorten Østergaard Andersen, Kenneth Alan Howard, Jørgen Kjems
Cancer Letters|October 22, 2013
Polycation-based nanoparticles for RNAi-mediated cancer treatmentBorja Ballarín-González, Morten Frendø Ebbesen, Kenneth Alan Howard
Drug Delivery and Translational Research|March 20, 2015
Clinical translation of RNAi-based treatments for respiratory diseasesBorja Ballarín-González, Troels Bo Thomsen, Kenneth Alan Howard
Drug Delivery and Translational Research|March 20, 2015
The application of RNAi-based treatments for inflammatory bowel diseaseMorten Tobias Jarlstad Olesen, Borja Ballarín-González, Kenneth Alan Howard
Journal of Drug Targeting|June 18, 2009
Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epitheliumAlpesh Mistry, Sys Zoffmann Glud, Jørgen Kjems, et al.
ACS Nano|May 25, 2012
Chitosan/siRNA nanoparticles encapsulated in PLGA nanofibers for siRNA deliveryMenglin Chen, Shan Gao, Mingdong Dong, et al.
Pageof 2